PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, The Cooper's PE Ratio without NRI is 18.68. The Cooper's 5-Year EBITDA growth rate is 5.20%. Therefore, The Cooper's PEG Ratio for today is 3.59.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for The Cooper's PEG Ratio or its related term are showing as below:
COO'
s PEG Ratio Range Over the Past 10 Years
Min: 0.89 Med: 3.28 Max: 10
Current: 3.59
During the past 13 years, The Cooper's highest PEG Ratio was 10.00. The lowest was 0.89. And the median was 3.28.
COO's PEG Ratio is ranked worse than 72.22% of 252
companies
in the Medical Devices & Instruments industry
Industry Median: 1.665
vs COO: 3.59
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
The Cooper PEG Ratio Historical Data
The historical data trend for The Cooper's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, The Cooper's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper PEG Ratio Distribution
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's PEG Ratio distribution charts can be found below:
* The bar in red indicates where The Cooper's PEG Ratio falls into.
The Cooper PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The Cooper (NAS:COO) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
The Cooper PEG Ratio Related Terms
Thank you for viewing the detailed overview of The Cooper's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 